查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372939

奈米孔定序市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、按核苷酸定序、按類型、按奈米孔類型、按應用、按最終用戶、按地區和競爭細分

Nanopore Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Nucleotide Sequenced, By Type, By Type of Nanopore, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 173 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

到2022 年，全球奈米孔定序市場價值為2.9131 億美元，預計到2028 年，預測期內將出現令人印象深刻的成長，年複合成長率為17.57%。奈米孔定序是用於生物聚合物定序的第三代技術，特別是多核苷酸，例如DNA 或 RNA 以及其他成分。這種先進的方法能夠分析單分子 DNA 或 RNA，無需對樣本進行 PCR 擴增或化學標記。奈米孔定序憑藉其具有成本效益的基因分型、增強的測試流動性以及快速樣品處理和即時結果的潛力，處於定序技術的前沿。透過測量分子通過奈米孔時電流的波動，可以準確識別給定核酸的序列。作為尖端的第四代技術，奈米孔定序涉及單一 DNA 或 RNA 鏈通過稱為奈米孔的微小蛋白質通道。這些奈米孔嵌入電阻膜內，引起離子電流的變化，促進鹼基序列和修飾的確定。這種機制為基因組學研究提供了寶貴的見解。

主要市場促進因素

各種研究應用對 DNA 定序的需求不斷增加

市場概況
預測期 2024-2028
2022 年市場規模 2.9131億美元
2028 年市場規模 74249萬美元
2023-2028 年年複合成長率 17.57%
成長最快的細分市場 耗材
最大的市場 北美洲

各種研究應用對 DNA 定序的需求不斷增加，推動了對奈米孔定序技術的需求激增。奈米孔定序是一種革命性的方法，可以對 DNA、RNA 和其他生物分子進行即時、單分子分析。其多功能性和獨特優勢使其在基因組學、遺傳學等領域越來越受歡迎。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球奈米孔定序市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品（消耗品與儀器）
    • 透過核苷酸定序（DNA vs RNA）
    • 按類型（直流定序、合成 DNA 和水平隧道電流定序、光學讀取技術定序、核酸外切酶定序）
    • 依奈米孔類型（固態、生物、混合）
    • 按應用（人類遺傳學、臨床研究、植物研究、微生物學、動物研究）
    • 按最終用戶（生物技術公司、臨床實驗室、學術和研究機構）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美奈米孔定序市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 透過核苷酸定序
    • 按類型
    • 依奈米孔類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲奈米孔定序市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 透過核苷酸定序
    • 按類型
    • 依奈米孔類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區奈米孔定序市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 透過核苷酸定序
    • 按類型
    • 依奈米孔類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲奈米孔定序市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 透過核苷酸定序
    • 按類型
    • 依奈米孔類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東與非洲奈米孔定序市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按產品分類
    • 透過核苷酸定序
    • 按類型
    • 依奈米孔類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非奈米孔定序
    • 沙烏地阿拉伯奈米孔定序
    • 阿拉伯聯合大公國奈米孔定序

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球奈米孔定序市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Oxford Nanopore Technologies plc
    • Illumnia, Inc.
    • F. Hoffmann-La Roche AG
    • 10X Genomics, Inc.
    • Agilent Technolgies, Inc.
    • NabSys, Inc.
    • Sequenom, Inc.
    • Quantapore, Inc.
    • InanoBio Inc.
    • Electronic BioSciences, Inc.

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 7677

lobal Nanopore Sequencing Market has valued at USD 291.31 Million in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 17.57% through 2028. Nanopore sequencing is a third-generation technique utilized for the sequencing of biopolymers, specifically polynucleotides such as DNA or RNA, along with other components. This advanced method enables the analysis of single molecule DNA or RNA without the need for PCR amplification or chemical labeling of the sample. With its potential for cost-effective genotyping, enhanced mobility for testing, and rapid sample processing with real-time results, nanopore sequencing stands at the forefront of sequencing technologies. By measuring fluctuations in electric current as the molecule passes through a nanopore, the sequence of the given nucleic acid can be accurately identified. As a cutting-edge fourth-generation technology, nanopore sequencing involves the passage of individual DNA or RNA strands through minuscule protein channels called nanopores. Embedded within an electrically resistant membrane, these nanopores induce alterations in ion current, facilitating the determination of base sequences and modifications. This mechanism offers invaluable insights in genomics research.

Key Market Drivers

Increase In Demand for DNA Sequencing For Various Application For Research

Market Overview
Forecast Period2024-2028
Market Size 2022USD 291.31 Million
Market Size 2028USD 742.49 Million
CAGR 2023-202817.57%
Fastest Growing SegmentConsumables
Largest MarketNorth America

The increase in demand for DNA sequencing across various research applications is driving a surge in the demand for nanopore sequencing technology. Nanopore sequencing is a revolutionary method that allows for the real-time, single-molecule analysis of DNA, RNA, and other biomolecules. Its versatility and unique advantages make it increasingly popular in the fields of genomics, genetics, and beyond.

One of the primary drivers for the growing demand of nanopore sequencing is its broad range of applications. Researchers are using nanopore sequencing for diverse purposes, including genome sequencing, metagenomics, epigenomics, transcriptomics, and more. Its ability to directly read long DNA strands and detect base modifications in real-time offers a comprehensive view of genetic information, enabling scientists to address complex biological questions. Furthermore, nanopore sequencing is known for its portability and rapid turnaround time. Compact nanopore sequencers, such as those offered by Oxford Nanopore Technologies, allow researchers to perform sequencing experiments in a variety of settings, including remote or field-based environments. This feature has opened up new possibilities for on-site genomics research, infectious disease monitoring, and environmental analysis.

Additionally, the continuous advancement of nanopore sequencing technology is expanding its applications further. Improved accuracy, longer read lengths, and lower sequencing costs are making nanopore sequencing more attractive to researchers. As the technology matures and becomes more cost-effective, it is increasingly integrated into research pipelines and clinical diagnostics. The surge in demand for DNA sequencing across diverse research areas is propelling the adoption of nanopore sequencing technology. Its versatility, portability, and continuous improvements make it a valuable tool for scientists seeking comprehensive genetic insights and real-time data, contributing to groundbreaking discoveries and advancements in various fields of study. As nanopore sequencing continues to evolve, its role in genomics and beyond is likely to expand even further, driving sustained demand for this innovative technology.

Partnerships and Acquisition to Boost Adoption and Co-Develop Advanced Solutions

The rapidly growing nanopore sequencing market has witnessed a multitude of strategic partnerships and acquisitions by key market players. These collaborative endeavors, driven by a shared vision, not only aim to amplify the adoption of this cutting-edge technology for clinical applications but also to collectively foster the development of state-of-the-art sequencing platforms that will truly revolutionize the field.

By leveraging the expertise, knowledge, and resources of multiple stakeholders, these alliances seek to unlock the full potential of nanopore sequencing. Through collaborative efforts, advancements in genomic research and precision medicine can be propelled to unprecedented levels, paving the way for groundbreaking discoveries and personalized treatments.

The significance of these strategic alliances and acquisitions within the market cannot be overstated. They serve as a testament to the immense potential and transformative power of nanopore sequencing in shaping the future of healthcare and personalized medicine. These partnerships lay a solid foundation for continued innovation, pushing the boundaries of what is possible and opening new horizons in the field of genomics.

As the nanopore sequencing market continues to evolve, these strategic alliances will play a crucial role in driving advancements, accelerating research, and ultimately improving patient outcomes. The collaborative efforts of industry leaders underscore the commitment to innovation and the shared goal of revolutionizing healthcare through the power of nanopore sequencing technology.

Introduction Of Internet of Things

The introduction of Internet of Things (IoT) has greatly benefited nanopore technology. With the ability to easily connect sequencers to other technical systems, healthcare professionals can now monitor DNA samples on shared cloud computing labs. This advancement is anticipated to not only aid in the growth of the market in the forecast period but also revolutionize genomics by expanding its applications to a wider range of needs. The convergence of ultrafast nanopore sequencing, biosensors, cloud computing, computational intelligence algorithms, and other related technologies has paved the way for new possibilities in genomics research.

Moreover, nanopore-based sequencers, as the fourth-generation DNA sequencing technology, hold immense potential. They offer the ability to quickly and reliably sequence the entire human genome for less than USD1000, and possibly even less than USD100. The utilization of single-molecule techniques by this technology also enables further study of the intricate interactions between DNA and proteins, as well as between different proteins. This enhanced understanding of molecular interactions opens up new opportunities for advancements in various fields, including medicine, biotechnology, and beyond.

Increase In R&D On Nanopore sequencing

The increase in research and development (R&D) efforts focused on nanopore sequencing is significantly driving up the demand for nanopore sequencing. Nanopore sequencing, a cutting-edge method in genomics, relies on the use of nanopores, tiny openings at the nanoscale level, to analyze individual DNA or RNA molecules as they pass through these pores. Intensive R&D investments are leading to continuous advancements in nanopore sequencing. Researchers are working to refine the design, materials, and manufacturing processes of nanopore sequencing devices. These improvements result in more reliable and accurate sequencing platforms, which in turn boost the appeal of nanopore sequencing for various applications. R&D efforts are driving down the cost of producing nanopore sequencing devices and reagents. As manufacturing processes become more efficient and scalable, the overall cost of nanopore sequencing decreases, making it more accessible to a wider range of researchers and laboratories.

Longer read lengths are a crucial aspect of sequencing technology, as they enable researchers to decipher complex genomic regions and perform de novo sequencing more effectively. R&D endeavors are extending the read lengths achievable with nanopore sequencing, further enhancing its utility in genomics research. Ongoing research into nanopore sequencing is uncovering new applications beyond genomics. These include epigenetics, structural biology, and the analysis of various biomolecules, such as proteins and RNA. As the range of applications widens, the demand for nanopore sequencing grows across diverse scientific disciplines. R&D is driving the development of smaller and more portable nanopore sequencing devices. These compact instruments can be utilized in various settings, including remote or point-of-care environments, broadening the potential use cases for nanopore sequencing.

Key Market Challenges

Higher Error Rate and Experimental Barriers

While nanopore sequencing technology offers numerous advantages, it also comes with certain limitations. These limitations include a higher error rate and the requirement of larger amounts of nucleic acid material compared to other sequencing technologies like sequencing by synthesis (SBS).

Researchers are actively working on substantial improvements to reduce the error rate and ensure high data accuracy. These efforts involve optimizing molecule translocation ratcheting, achieving context-independent and high-quality raw signals, and developing base-calling methods using advanced computational techniques like machine learning.

Currently, nanopore sequencing requires a few micrograms of DNA and hundreds of nanograms of RNA, which can be an experimental barrier. Reducing the sample size requirement would greatly benefit nanopore sequencing in various biomedical studies where genetic material is limited. Additionally, integrating and automating DNA/RNA extraction, library preparation, and loading systems would be highly beneficial for generating sequencing data without the need for specific training. The development of robust bioinformatics software that enables cloud storage, computing, and real-time analysis will further drive the adoption of nanopore sequencing across different applications and settings.

Despite the experimental challenges, the nanopore sequencing market is expected to grow significantly due to rapid advancements in this technology. Ongoing improvements in terms of read length, throughput, and accuracy aim to facilitate research and clinical applications such as rapid clinical diagnosis and outbreak surveillance.

Issues In Maintaining the Integration and Structure of The Nucleotide

Issues in maintaining the integration and structure of nucleotides are posing challenges that may potentially impact the demand for nanopore sequencing technology. While nanopore sequencing has shown immense promise in various genomics applications, it is not without limitations, and certain challenges associated with the preservation of nucleotide integrity are worth considering. Nanopore sequencing requires intact DNA or RNA molecules to pass through the nanopores for accurate sequencing. However, biological samples, especially those from older or degraded specimens, can suffer from DNA damage and fragmentation. Maintaining the structural integrity of nucleotides becomes critical in such cases, as damaged or fragmented molecules can lead to sequencing errors and reduced data quality.

Nucleotide modifications, such as methylation or hydroxymethylation, play crucial roles in gene regulation and epigenetics. Nanopore sequencing has the potential to detect these modifications directly, but maintaining the structural integrity of nucleotides during sequencing is essential for preserving this valuable epigenetic information accurately. Ongoing research and development efforts are addressing many of the issues related to maintaining nucleotide integrity in nanopore sequencing. Improved library preparation protocols, enhanced nanopore chemistry, and software advancements are gradually mitigating some of these concerns. However, it is essential for users to carefully assess their specific research needs and the quality of their nucleotide samples when considering the adoption of nanopore sequencing technology, particularly in applications where nucleotide structure is critical to the research outcome.

Key Market Trends

Use Of Nanopore sequencing for Fourth Generation DNA Sequencing

The surge in the use of nanopore sequencing for fourth-generation DNA sequencing is anticipated to offer a highly lucrative opportunity for market growth in the coming years. Nanopore-based sequencers, as the fourth-generation DNA sequencing technology, have shown tremendous potential in quickly and reliably sequencing the entire human genome for less than USD 1000, and possibly even less than USD 100. This significant decrease in the cost of nanopore sequencing for analyzing different types of sequences is expected to capture the attention of a majority of healthcare professionals, including researchers, clinicians, and geneticists. With the ability to provide fast and accurate DNA sequencing results at a fraction of the cost of traditional methods, nanopore sequencing have the potential to revolutionize the field of genomics. This advancement will not only make DNA sequencing more accessible and affordable for a wider range of applications but also enable new discoveries and advancements in personalized medicine, genetic research, and disease diagnosis. The integration of nanopore sequencing into healthcare settings has the potential to transform the way we understand and treat genetic diseases, paving the way for more targeted and effective therapies. As the adoption of nanopore-based sequencers continues to grow, the market is poised for significant expansion, presenting exciting opportunities for companies operating in the genomics and biotechnology sectors.

Miniaturization and Portability

Nanopore sequencers will continue to become smaller and more portable. Handheld or field-deployable devices will enable on-site sequencing in remote locations, disaster response scenarios, and point-of-care applications. Researchers and engineers are working to reduce the size and weight of nanopore sequencing devices. This involves shrinking the electronics, improving heat management, and optimizing power consumption to create more compact instruments. Field-deployable devices need to withstand harsh conditions, including temperature variations, humidity, and physical shocks. Robust construction and ruggedized designs will be essential to ensure the reliability of these devices.

Simplified sample preparation techniques will be designed to minimize the need for extensive laboratory equipment and expertise. These techniques will be tailored to the unique requirements of portable nanopore sequencers. Handheld sequencers will be part of a broader ecosystem that includes field laboratories equipped with portable DNA extraction and sample preparation systems. This integration ensures a seamless workflow from sample collection to sequencing in remote locations. Portable nanopore sequencers will be designed with specific field applications in mind, such as monitoring infectious disease outbreaks, studying environmental microbiomes, or performing rapid diagnostics in point-of-care settings.

Segmental Insights

Product Insights

Based on the comprehensive product analysis, it is evident that the consumables segment is the primary contributor to revenue and is projected to experience substantial growth throughout the entire forecast period. This can be attributed to the notable surge in the utilization of consumables across a wide range of procedures, including DNA sequencing and RNA sequencing, which are crucial in advancing scientific research and innovation in the field of genomics.

Furthermore, the rising adoption of consumables in previously unexplored applications, such as the sequencing of novel viruses, is expected to further bolster the segment's market share. This expansion into new territories highlights the adaptability and versatility of consumables, showcasing their vital role in addressing emerging challenges and exploring new frontiers in genomics. As the demand for advanced genetic analysis continues to increase, the significance of consumables cannot be overstated. They serve as the backbone of scientific advancements, facilitating breakthrough discoveries and enabling researchers to unravel the complexities of the genetic code. With their pivotal role in enhancing the accuracy, efficiency, and reliability of genomics research, consumables are poised to shape the future of scientific exploration and contribute to the ongoing progress in the field.

End User Insights

Based on end user, the global market was predominantly led by Academic & Research Institutes, a trend that is expected to continue in the foreseeable future. This dominance can be attributed to the surging demand for nanopore sequencing in research institutes, which are increasingly recognized for their immense potential to revolutionize various fields of study. The adoption of nanopore sequencing by these institutes has not only facilitated ground-breaking research but has also paved the way for remarkable discoveries, further solidifying their position as key drivers of innovation in the market. With their unwavering commitment to pushing the boundaries of scientific exploration, Academic & Research Institutes are poised to shape the future of technological advancements and continue to fuel the progress of the market.

Regional Insights

North America is well-positioned to dominate the market during the forecast period. This is primarily due to the increasing demand for nanopore sequencing, driven by the rising incidences of viral diseases in the region. Moreover, the presence of major key players in North America further strengthens its market position. Additionally, the growing targeted patient population and higher healthcare expenditure contribute to the region's market growth. The favorable government policies for research in nanopore sequencing also act as a catalyst for market expansion in the coming years.

Furthermore, Asia-Pacific, South America, and the Middle East and Africa (MEA) present lucrative opportunities for key players in the nanopore technology market. The increasing number of hospitals equipped with nanopore technology modalities and the significant utilization of nanopore sequencing in these regions contribute to their market potential. Moreover, the market is anticipated to witness growth in the next few years, fueled by the rising geriatric population, which is more susceptible to viral diseases.

The market outlook for nanopore sequencing is promising, with North America leading the way and other regions offering significant growth opportunities. The combination of increasing demand, favorable government policies, and the rising geriatric population sets the stage for continued market expansion in the coming years.

Key Market Players

Oxford Nanopore Technologies plc

Illumnia, Inc.

F. Hoffmann-La Roche AG

10X Genomics, Inc.

Agilent Technolgies, Inc.

NabSys, Inc.

Sequenom, Inc.

Quantapore, Inc.

InanoBio Inc.

Electronic BioSciences, Inc.

Report Scope:

In this report, the Global Nanopore Sequencing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nanopore Sequencing Market, By Product:

  • Consumables
  • Instruments

Nanopore Sequencing Market, By Nucleotide Sequenced:

  • DNA
  • RNA

Nanopore Sequencing Market, By Type:

  • Direct Current Sequencing
  • Synthetic DNA and Horizontal Tunnelling Current Sequencing
  • Optical Reading Techniques Sequencing
  • Exonuclease Sequencing

Nanopore Sequencing Market, By Type of Nanopore:

  • Solid State
  • Biological
  • Hybrid

Nanopore Sequencing Market, By Type of Application:

  • Human Genetics
  • Clinical Research
  • Plant Research
  • Microbiology
  • Animal Research

Nanopore Sequencing Market, By Type of End User:

  • Biotechnology Companies
  • Clinical Laboratories
  • Academic & Research Institutes

Nanopore Sequencing Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Nanopore Sequencing Market.

Available Customizations:

  • Global Nanopore Sequencing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nanopore Sequencing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Consumables v/s Instruments)
    • 5.2.2. By Nucleotide Sequenced (DNA v/s RNA)
    • 5.2.3. By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing)
    • 5.2.4. By Type of Nanopore (Solid State, Biological, Hybrid)
    • 5.2.5. By Application (Human Genetics, Clinical Research, Plant Research, Microbiology, Animal Research)
    • 5.2.6. By End User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes)
    • 5.2.7. By Region
    • 5.2.8. By Company (2022)
  • 5.3. Market Map

6. North America Nanopore Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Nucleotide Sequenced
    • 6.2.3. By Type
    • 6.2.4. By Type of Nanopore
    • 6.2.5. By Application
    • 6.2.6. By End User
    • 6.2.7. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nanopore Sequencing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Nucleotide Sequenced
        • 6.3.1.2.3. By Type
        • 6.3.1.2.4. By Type of Nanopore
        • 6.3.1.2.5. By Application
        • 6.3.1.2.6. By End User
    • 6.3.2. Canada Nanopore Sequencing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Nucleotide Sequenced
        • 6.3.2.2.3. By Type
        • 6.3.2.2.4. By Type of Nanopore
        • 6.3.2.2.5. By Application
        • 6.3.2.2.6. By End User
    • 6.3.3. Mexico Nanopore Sequencing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Nucleotide Sequenced
        • 6.3.3.2.3. By Type
        • 6.3.3.2.4. By Type of Nanopore
        • 6.3.3.2.5. By Application
        • 6.3.3.2.6. By End User

7. Europe Nanopore Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Nucleotide Sequenced
    • 7.2.3. By Type
    • 7.2.4. By Type of Nanopore
    • 7.2.5. By Application
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Nanopore Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Nucleotide Sequenced
        • 7.3.1.2.3. By Type
        • 7.3.1.2.4. By Type of Nanopore
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By End User
    • 7.3.2. United Kingdom Nanopore Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Nucleotide Sequenced
        • 7.3.2.2.3. By Type
        • 7.3.2.2.4. By Type of Nanopore
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By End User
    • 7.3.3. Italy Nanopore Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Nucleotide Sequenced
        • 7.3.3.2.3. By Type
        • 7.3.3.2.4. By Type of Nanopore
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By End User
    • 7.3.4. France Nanopore Sequencing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Nucleotide Sequenced
        • 7.3.4.2.3. By Type
        • 7.3.4.2.4. By Type of Nanopore
        • 7.3.4.2.5. By Application
        • 7.3.4.2.6. By End User
    • 7.3.5. Spain Nanopore Sequencing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Nucleotide Sequenced
        • 7.3.5.2.3. By Type
        • 7.3.5.2.4. By Type of Nanopore
        • 7.3.5.2.5. By Application
        • 7.3.5.2.6. By End User

8. Asia-Pacific Nanopore Sequencing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Nucleotide Sequenced
    • 8.2.3. By Type
    • 8.2.4. By Type of Nanopore
    • 8.2.5. By Application
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Nanopore Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Nucleotide Sequenced
        • 8.3.1.2.3. By Type
        • 8.3.1.2.4. By Type of Nanopore
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By End User
    • 8.3.2. India Nanopore Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Nucleotide Sequenced
        • 8.3.2.2.3. By Type
        • 8.3.2.2.4. By Type of Nanopore
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By End User
    • 8.3.3. Japan Nanopore Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Nucleotide Sequenced
        • 8.3.3.2.3. By Type
        • 8.3.3.2.4. By Type of Nanopore
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By End User
    • 8.3.4. South Korea Nanopore Sequencing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Nucleotide Sequenced
        • 8.3.4.2.3. By Type
        • 8.3.4.2.4. By Type of Nanopore
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By End User
    • 8.3.5. Australia Nanopore Sequencing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Nucleotide Sequenced
        • 8.3.5.2.3. By Type
        • 8.3.5.2.4. By Type of Nanopore
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By End User

9. South America Nanopore Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Nucleotide Sequenced
    • 9.2.3. By Type
    • 9.2.4. By Type of Nanopore
    • 9.2.5. By Application
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Nanopore Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Nucleotide Sequenced
        • 9.3.1.2.3. By Type
        • 9.3.1.2.4. By Type of Nanopore
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By End User
    • 9.3.2. Argentina Nanopore Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Nucleotide Sequenced
        • 9.3.2.2.3. By Type
        • 9.3.2.2.4. By Type of Nanopore
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By End User
    • 9.3.3. Colombia Nanopore Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Nucleotide Sequenced
        • 9.3.3.2.3. By Type
        • 9.3.3.2.4. By Type of Nanopore
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By End User

10. Middle East and Africa Nanopore Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Nucleotide Sequenced
    • 10.2.3. By Type
    • 10.2.4. By Type of Nanopore
    • 10.2.5. By Application
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Nanopore Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Nucleotide Sequenced
        • 10.3.1.2.3. By Type
        • 10.3.1.2.4. By Type of Nanopore
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By End User
    • 10.3.2. Saudi Arabia Nanopore Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Nucleotide Sequenced
        • 10.3.2.2.3. By Type
        • 10.3.2.2.4. By Type of Nanopore
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By End User
    • 10.3.3. UAE Nanopore Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Nucleotide Sequenced
        • 10.3.3.2.3. By Type
        • 10.3.3.2.4. By Type of Nanopore
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Nanopore Sequencing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Oxford Nanopore Technologies plc
    • 15.5.2. Illumnia, Inc.
    • 15.5.3. F. Hoffmann-La Roche AG
    • 15.5.4. 10X Genomics, Inc.
    • 15.5.5. Agilent Technolgies, Inc.
    • 15.5.6. NabSys, Inc.
    • 15.5.7. Sequenom, Inc.
    • 15.5.8. Quantapore, Inc.
    • 15.5.9. InanoBio Inc.
    • 15.5.10. Electronic BioSciences, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer